Overview of fat-soluble vitamin deficiencies
The fat-soluble vitamins (A, D, E and K) require bile for absorption from the gastrointestinal tract, and travel through the lymphatic system before entering circulation. Fat-soluble vitamins are not easily excreted, and the risk of toxicity is greater than with water-soluble vitamins. Excesses are stored primarily in the liver and adipose tissues, so deficiencies may not be seen until weeks or months of inadequate intake. People with conditions causing fat malabsorption (eg cystic fibrosis, pancreatic insufficiency, short bowel syndrome, bariatric surgery) are at higher risk of fat-soluble vitamin deficiencies.
See Clinical aspects of fat-soluble vitamins for the physiological function of fat-soluble vitamins, and the effects and risk factors for deficiency.
Dietary sources of fat-soluble vitamins are listed in Dietary sources of key vitamins, minerals and trace elements.
The evidence for the optimal dosage of fat-soluble vitamins and outcomes is limited; dosages given in this topic are a guide only.
People deficient in multiple fat-soluble vitamins or with a condition causing fat malabsorption can be treated with a water-miscible, high-potency fat-soluble multivitamin formulation such as VitABDECK (contains vitamin A 2500 international units [IU], vitamin D 440 IU, vitamin E 150 IU, and vitamin K 150 micrograms). People deficient in a specific fat-soluble vitamin may only need treatment with a high-dose supplement of that vitamin.
Baseline testing of fat-soluble vitamin blood concentration should only be carried out in people at risk of deficiency. Repeat testing may be used to determine if the patient is having an adequate response to therapy and to ensure that the patient is not receiving an excessive dosage; however, evidence to guide timing of repeat testing is lacking. Disease-specific guidelines may provide recommendations for the frequency of repeat testing. In general, the requirement for and frequency of repeat testing should be individualised based on which micronutrient is supplemented and the severity of the deficiency. For information about the requirement for and frequency of vitamin D testing, see Vitamin D treatment regimens.
Supplementation of fat-soluble vitamins should not continue indefinitely. To avoid toxicity, recheck blood concentration after 3 months, if appropriate, and stop supplementation if the deficiency has resolved. Long-term supplementation may be required in patients with a chronic condition causing fat malabsorption.
vitamin A | |
physiological function | protein synthesis and cell differentiation maintains vision maintains health of epithelial tissues and skin supports reproduction and growth |
effects of deficiency | impaired night vision xerophthalmia (conjunctival and corneal dryness) loss of integrity of skin and mucous membranes resulting in poor absorption of nutrients decreased immune function plugging of hair follicles painful joints related to cessation of bone growth |
risk factors for deficiency | liver disease cystic fibrosis and other fat malabsorption syndromes anorexia nervosa very low-fat diets (particularly if vegetarian or vegan) chronic infection |
vitamin D | |
physiological function | bone health—maintains calcium and phosphate homeostasis (enhances their absorption from gastrointestinal tract, reabsorption from kidneys, and mobilisation from bone into blood) |
effects of deficiency | osteomalacia (adults) rickets (children) impaired modulation of immune and neuromuscular systems |
risk factors for deficiency | dark skin, no sun exposure elderly with limited sun exposure inadequate calcium intake liver disease, untreated coeliac disease, kidney disease and other malabsorption conditions corticosteroid use |
vitamin E | |
physiological function | antioxidant in cell membranes; protects against fatty acid peroxidation |
effects of deficiency | haemolytic anaemia central or peripheral neuropathy, myopathy increased atherosclerosis |
risk factors for deficiency | cystic fibrosis and other fat malabsorption syndromes premature infants |
vitamin K | |
physiological function | blood coagulation; activates several clotting factors, including prothrombin bone calcification |
effects of deficiency | bleeding disorders may cause decreased bone density |
risk factors for deficiency | cystic fibrosis and other fat malabsorption syndromes prolonged use of antibiotics |